Recurrent Respiratory Papillomatosis (RRP) is a rare disease that causes wart-like growths in the airways. These growths can be removed by surgery but typically grow back. A clinical trial led by Scott M. Norberg, D.O., Assistant Research Physician in the Center for Immuno-Oncology, is researching a drug therapy that may help reduce necessary surgeries for RRP. The trial will take place at the NIH Clinical Center in Bethesda, Maryland, and there is no cost for participation.
For more information, please contact Melissa L. Wheatley at (240) 858-3391 or firstname.lastname@example.org
Clinicaltrials.gov identifier: NCT05797246
NCI Protocol ID: IRB001572
Official Title: A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)